Cardiff Park Advisors’s NextCure NXTC Stock Holding History

Cardiff Park Advisors’s Portfolio NXTC Stock Details NXTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$233K	Hold	21,833	–	–	0.02%	260
2025 Q4	$310K	Hold	21,833	–	–	0.03%	213
2025 Q3	$128K	Hold	21,833	–	–	0.01%	308
2025 Q2	$121K	Hold	21,833	–	–	0.01%	281
2025 Q1	$126K	Hold	21,833	–	–	0.01%	277
2024 Q4	$202K	Hold	21,833	–	–	0.02%	254
2024 Q3	$359K	Hold	21,833	–	–	0.03%	187
2024 Q2	$417K	Hold	21,833	–	–	0.04%	171
2024 Q1	$584K	Buy	+21,833	New	+$376K	0.06%	151
2023 Q3	–	Sell	-21,833	Closed	-$472K	–	321
2023 Q2	$472K	Buy	+21,833	New	+$430K	0.06%	152
2023 Q1	–	Sell	-21,833	Closed	-$369K	–	327
2022 Q4	$369K	Buy	+21,833	New	+$502K	0.05%	173

Other funds holding NXTC

SCM

Squadron Capital Management Westmont, Illinois $273M AUM

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

EAM

Exome Asset Management New York $193M AUM 208.51% 1-Year Est. Return

Cardiff Park Advisors's NXTC Position: Q1 2026 in Review

Cardiff Park Advisors held its NextCure (NXTC) position steady in Q1 2026 at 21,833 shares worth $233K. The position accounts for 0.02% of the portfolio, ranked #260.

Cardiff Park Advisors first reported a position in NXTC in Q4 2022 and has held it in 11 quarters since. The position peaked at $584K in Q1 2024. 26 funds tracked by Wall St. Rank hold NXTC as of Q1 2026.

Cardiff Park Advisors held 21,833 shares of NextCure worth $233K as of Q1 2026.
Cardiff Park Advisors left its NextCure share count unchanged in Q1 2026.
NextCure made up 0.02% of Cardiff Park Advisors's portfolio in Q1 2026, its #260 holding.
Cardiff Park Advisors first reported a position in NextCure in Q4 2022 and has held it in 11 quarters since.
Cardiff Park Advisors's NextCure position peaked at $584K in Q1 2024.
26 funds tracked by Wall St. Rank held NextCure as of Q1 2026.

Based on Cardiff Park Advisors's 13F filing for Q1 2026, filed 15 May 2026.